Cargando…
Changes in the gut microbiome associated with infliximab in patients with bipolar disorder
OBJECTIVES: Available information exists supporting the gut–brain axis, but additional information is needed to explore how the gut microbiome changes when exposed to mood disorder treatments. We sought to explore the effects of a novel treatment for bipolar disorder (BD), infliximab, on the gut mic...
Autores principales: | Bharwani, Aadil, Szamosi, Jake C., Taylor, Valerie H., Lee, Yena, Bala, Asem, Mansur, Rodrigo, Subramaniapillai, Mehala, Surette, Michael, McIntyre, Roger S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413825/ https://www.ncbi.nlm.nih.gov/pubmed/34152099 http://dx.doi.org/10.1002/brb3.2259 |
Ejemplares similares
-
Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
por: Mansur, Rodrigo B., et al.
Publicado: (2020) -
Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder
por: Subramaniapillai, Mehala, et al.
Publicado: (2016) -
The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019) -
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018) -
Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis
por: Lee, Yena, et al.
Publicado: (2022)